December 13, 2016 / 12:22 PM / 8 months ago

BRIEF-Acelrx Pharmaceuticals submits drug application for acute pain treatment

Dec 13 (Reuters) - Acelrx Pharmaceuticals Inc

* Acelrx Pharmaceuticals submits new drug application for ARX-04 for the treatment of moderate-to-severe acute pain

* Using NDA for marketing authorization application for ARX-04 to european medicines agency with target submission date in H1 2017 Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below